NCT02545101View on ClinicalTrials.gov

An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
HyponatremiaSyndrome of Inappropriate ADH (SIADH) Secretion
Trial Locations (7)

Unknown

Bochum

Chemnitz

Dresden

Lübeck

Córdoba

Madrid

Santiago de Compostela

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Europe Ltd

INDUSTRY

NCT02545101 - An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH | Biotech Hunter | Biotech Hunter